Albrecht W - Search Results

1

Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.

Laufer SA, Domeyer DM, Scior TR, Albrecht W, Hauser DR. Laufer SA, et al. Among authors: albrecht w. J Med Chem. 2005 Feb 10;48(3):710-22. doi: 10.1021/jm0408767. J Med Chem. 2005. PMID: 15689155

2

Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor.

Kammerer B, Scheible H, Albrecht W, Gleiter CH, Laufer S. Kammerer B, et al. Among authors: albrecht w. Drug Metab Dispos. 2007 Jun;35(6):875-83. doi: 10.1124/dmd.106.013409. Epub 2007 Mar 7. Drug Metab Dispos. 2007. PMID: 17344341

3

IL-1beta regulates FHL2 and other cytoskeleton-related genes in human chondrocytes.

Joos H, Albrecht W, Laufer S, Reichel H, Brenner RE. Joos H, et al. Among authors: albrecht w. Mol Med. 2008 Mar-Apr;14(3-4):150-9. doi: 10.2119/2007-00118.Joos. Mol Med. 2008. PMID: 18224250 Free PMC article.

4

In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase.

Albrecht W, Unger A, Nussler AK, Laufer S. Albrecht W, et al. Drug Metab Dispos. 2008 May;36(5):894-903. doi: 10.1124/dmd.108.020347. Epub 2008 Feb 11. Drug Metab Dispos. 2008. PMID: 18268076

5

Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.

Koeberle A, Siemoneit U, Bühring U, Northoff H, Laufer S, Albrecht W, Werz O. Koeberle A, et al. Among authors: albrecht w. J Pharmacol Exp Ther. 2008 Sep;326(3):975-82. doi: 10.1124/jpet.108.139444. Epub 2008 Jun 11. J Pharmacol Exp Ther. 2008. PMID: 18550688

6

Influence of p38MAPK inhibition on IL-1beta-stimulated human chondrocytes: a microarray approach.

Joos H, Albrecht W, Laufer S, Brenner RE. Joos H, et al. Among authors: albrecht w. Int J Mol Med. 2009 May;23(5):685-93. doi: 10.3892/ijmm_00000181. Int J Mol Med. 2009. PMID: 19360329

7

2-Acylaminopyridin-4-ylimidazoles as p38 MAP kinase inhibitors: Design, synthesis, and biological and metabolic evaluations.

Ziegler K, Hauser DR, Unger A, Albrecht W, Laufer SA. Ziegler K, et al. Among authors: albrecht w. ChemMedChem. 2009 Nov;4(11):1939-48. doi: 10.1002/cmdc.200900242. ChemMedChem. 2009. PMID: 19731280

8

Synthesis and biological testing of N-aminoimidazole-based p38alpha MAP kinase inhibitors.

Bracht C, Hauser DR, Schattel V, Albrecht W, Laufer SA. Bracht C, et al. Among authors: albrecht w. ChemMedChem. 2010 Jul 5;5(7):1134-42. doi: 10.1002/cmdc.201000114. ChemMedChem. 2010. PMID: 20473979

9

Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors.

Laufer S, Hauser D, Stegmiller T, Bracht C, Ruff K, Schattel V, Albrecht W, Koch P. Laufer S, et al. Among authors: albrecht w. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6671-5. doi: 10.1016/j.bmcl.2010.09.012. Epub 2010 Sep 9. Bioorg Med Chem Lett. 2010. PMID: 20934337

10

Chiral sulfoxides as metabolites of 2-thioimidazole-based p38α mitogen-activated protein kinase inhibitors: enantioselective synthesis and biological evaluation.

Bühler S, Goettert M, Schollmeyer D, Albrecht W, Laufer SA. Bühler S, et al. Among authors: albrecht w. J Med Chem. 2011 May 12;54(9):3283-97. doi: 10.1021/jm101623p. Epub 2011 Apr 12. J Med Chem. 2011. PMID: 21449619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters